COMPARISON OF THE DIAGNOSTIC VALUE OF MRI AND ULTRASOUND IN THE STUDIED PATIENTS AND DETERMINATION OF PROGNOSTIC FACTORS OF ENDOMETRIAL CANCER

Authors
  • Dilfuzahon Mamarasulova Zakirjanovna

    Professor at the Department of Medical Oncology, Andijan State Medical Institute, Andijan, Uzbekistan
  • Mirzakarimov Bakhromjon Khalimjonovich

    The Head of the Department of Pediatric Surgery
  • Abdurakhmanov Farrukh Saidazimovich

    Assistant of the Department of Pediatric Surgery
  • Kadirov Komiljon Zakirdjanovich

    Assistant Professor of the Department of Pediatric Surgery
Keywords:
Malignant neoplasms, endometrial cancer
Abstract

Endometrial cancer (EM) is the most common malignant tumor in women, most often of reproductive age. EC are detected, according to various sources, in 25 - 50% of women under the age of 50 years. We analyzed the results of examination and treatment of 98 patients. The criterion for inclusion in this study was a morphologically verified squamous EC of stages IB2, IIB and IIIB, the results showed that it is advisable to subject endometrial cancer patients with identified metastases to a special one (chemo, chemoradiotherapy followed by radical operations), as this leads to improved results (in in our study by more than 20%) and an increase in the life expectancy of these patients, also, depending on the stage, depth of tumor invasion and those treated with neoadjuvant chemotherapy and subsequent radical operations: for example, the five-year relapse-free and overall survival rates were 79.6% and 87 .5%, respectively, in patients with EC stages IB2 - IIIB, which is approximately 20% higher than similar indicators among patients who underwent only combined radiation therapy.